Governance & Councils

Members of the Board


  • Mr. Tjerk DE RUITER, Chief Executive Officer, representing Corbion


  • Dr. Carsten SIEDEN, Chair of the EuropaBio Industrial Biotechnology Council, Senior Vice President White Biotechnology Research, representing BASF
  • Dr. Peter HEINRICH, Chair of the EuropaBio SME Platform; representing BIO Deutschland e.V.
  • Mr Matthew MORAN, Chair of the EuropaBio National Associations Council; Head of the Irish Biotech Association, representing BioPharmaChem Ireland
  • Mr. Neil MULCOCK, Chair of the EuropaBio Healthcare Biotechnology Council; Vice President Government Affairs and Policy EMEA, representing Gilead  
  • Chair of the EuropaBio Agri-Food Council – [vacant]


  • [vacant]

Regular Members

  • Mr. Ion AROCENA VELEZ, General Manager, representing the Spanish Bioindustry Association (ASEBIO)
  • Mr. Steve BATES, Chief Executive Officer, representing the BioIndustry Association (BIA)
  • Mrs. Anouk DE VROEY, Senior Director Government Affairs & Policy EMEA, representing Janssen, Pharmaceutical Companies of Johnson & Johnson
  • Mr. David EARNSHAW, Associate Vice President for Public Policy Europe & Canada, representing MSD Europe Inc.
  • Dr. Ricardo GENT, Executive Director of the German Association of Biotechnology Industries (DIB)
  • Dr. Carlo INCERTI, Chairman of the Board, representing MolMed S.p.a.
  • Mr. Volker KOCH-ACHELPÖHLER, Head of the EU Liaison Office; representing Bayer AG
  • Mr. Peter KURTZHALS, Senior Vice President and Chief Scientific Advisor, representing Novo Nordisk A/S
  • Mr. Marcel LECHANTEUR, President and General Manager Lilly France, Benelux, North West Africa and European Affairs, representing Lilly
  • Mr. Macy MERRIMAN, Government and Industry Affairs Lead – Europe, Middle East, Africa, representing Corteva Agriscience
  • Dr. Maria Luisa NOLLI, representing Assobiotec
  • Dr. Walter PFEFFERLE, Senior Vice President New Business Development, representing Evonik Nutrition & Care GmbH
  • Dr. Marcus REMMERS, Chief Technology Officer, representing Royal DSM NV.
  • Mr. Andrew TOPEN, Head of Public Affairs Europe, representing Novartis
  • Prof. Dr. Arjen VAN TUNEN, CEO, representing Keygene
  • Mrs. Annemiek VERKAMMAN, Managing Director, representing HollandBIO 
  • Mr. Justin WOLFE, Europe, Africa and Middle East Head of Seeds, representing Syngenta

Secretary General


Nike Series